Get the latest news, insights, and market updates on ELAN (Elanco Animal Health Incorporated). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Protein, Science, Debate and Dietary Guidelines: Nina Teicholz
NORTHAMPTON, MA / ACCESS Newswire / January 30, 2026 /By Jeff Simmons Protein. It's everywhere. From our center of the plate favorites to protein popcorn, ramen to even protein-packed ice cream, it's clear - we're in the midst of a protein revolution. ... Jan 30, 2026 - $ELAN
Hardman Johnston Global Equity Strategy Initiated a Position in Elanco Animal Health (ELAN)
Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” investor letter for the fourth quarter of 2025. A copy of the letter can be downloaded here. Global equity markets delivered robust results in the quarter, backed by easing inflation trends and strong economic data. The Hardman Johnston Global Equity Strategy […] Jan 28, 2026 - $ELAN
How Piper Sandler’s Upgrade and New Vet-Channel Approvals Will Impact Elanco Animal Health (ELAN) Investors
Piper Sandler recently upgraded Elanco Animal Health to an Overweight rating, citing progress with corporate veterinary accounts and fresh regulatory approvals for key products such as Befrena and Credelio Quattro. These developments come after a period of muted revenue growth and negative returns on capital, making the improved access to corporate channels and pricing power a particularly important shift in the company’s story. We’ll now examine how the Piper Sandler upgrade, underpinned by... Jan 27, 2026 - $ELAN
A Look At Elanco Animal Health (ELAN) Valuation After Recent Analyst Upgrades And Regulatory Approvals
Piper Sandler and several other firms recently upgraded Elanco Animal Health (ELAN), citing progress with corporate veterinary accounts, pricing power on key products, and new regulatory approvals that have supported overall investor confidence. See our latest analysis for Elanco Animal Health. At a share price of $24.68, Elanco’s recent 30 day share price return of 9.20% and 90 day share price return of 11.57% sit alongside a 1 year total shareholder return of 104.47%. This performance... Jan 27, 2026 - $ELAN
2 Profitable Stocks to Own for Decades and 1 Facing Headwinds
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. Jan 27, 2026 - $ELAN
3 Mid-Cap Stocks with Open Questions
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo. Jan 26, 2026 - $ELAN
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple